Asthma treatment in primary care : Studies of variability and health economic aspects

摘要: Background: Most asthma patients in Sweden are treated primary care, but little is known about economic aspects of treatment that setting and the regional variation use antiasthmatics drugs adherence to national guidelines for of asthma. General aims: To analyze terms of classification severity, quality life, utilization, clinical practice costs from a societal perspective. Methods: A prospective cross-sectional design was used study the pharmaceutical their relationship life, asthma clinical lungfunction compare different approaches classifying all care. A cluster-randomized controlled trial carried out in primary care effect information monitoring on asthma control. variations antiasthmatics, registry study based Swedish National Prescribed Drug Register performed. In all studies, population consists adult patients. However, the registry study, there an upper limit 44 years age exclude patients with COPD-patients. Results conclusions: There large of pharmaceuticals between centers in Stockholm as well different regions. Asthma severity explains only small part pharmaceutical and does not account differences centers. When different approaches classify severity were tested, no strategy tested strategies superior. Adherence low among caregivers. There room improvement both control life of care. Adding structured information and by diary can improve patient s outcome.